Literature DB >> 16532282

[Bronchial obstruction in intensive care].

T Wagner1.   

Abstract

Bronchial obstruction due to one of the major pulmonary diseases asthma, COPD, or emphysema are a common problem in intensive care medicine as the leading cause or as comorbidity. While in pharmacological therapy no major changes have occurred during the last few years, two major advances have been reached in ventilation therapy which are in the focus of this review. First the non invasive ventilation (NIV) has been shown to prove efficient in treating acute on chronic respiratory failure in COPD patients and is capable of shortening the duration of hospital stay. In addition NIV can be used successfully in weaning after long time ventilator therapy and improve prognosis in COPD patients. Secondly the strategy of invasive ventilation therapy has changed significantly. "Permissive hypercapnia" is unequivocally established in severe bronchial obstruction in situations of limited ventilation. When intrinsic PEEP and elevated airway resistance are present PEEP may be useful and the upper limit of airways peak pressure that we are used to in "protective ventilation" of ARDS patients can be necessary and useful to exceed.

Entities:  

Mesh:

Year:  2006        PMID: 16532282     DOI: 10.1007/s00108-006-1589-8

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  37 in total

Review 1.  International Consensus Conferences in Intensive Care Medicine: noninvasive positive pressure ventilation in acute Respiratory failure.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2001-01       Impact factor: 21.405

Review 2.  Noninvasive ventilation for acute respiratory failure.

Authors:  Laurent Brochard
Journal:  JAMA       Date:  2002-08-28       Impact factor: 56.272

Review 3.  [Guidelines for the diagnosis and treatment chronic obstructive bronchitis and pulmonary emphysema issued by Deutsche Atemwegsliga and Deutsche Gesellschaft für pneumologie].

Authors:  H Worth; R Buhl; U Cegla; C P Criée; A Gillissen; P Kardos; D Köhler; H Magnussen; R Meister; D Nowak; W Petro; K F Rabe; G Schultze-Werninghaus; H Sitter; H Teschler; T Welte; R Wettengel
Journal:  Pneumologie       Date:  2002-11

4.  [Intermediate respiratory intensive care units: definitions and characteristics].

Authors:  A Torres; M Ferrer; J B Blanquer; M Calle; V Casolivé; J M Echave; D M Masa
Journal:  Arch Bronconeumol       Date:  2005-09       Impact factor: 4.872

5.  The effect of heliox in acute severe asthma: a randomized controlled trial.

Authors:  J E Kass; C A Terregino
Journal:  Chest       Date:  1999-08       Impact factor: 9.410

Review 6.  Complications associated with mechanical ventilation.

Authors:  D J Pierson
Journal:  Crit Care Clin       Date:  1990-07       Impact factor: 3.598

7.  Heliox improves hemodynamics in mechanically ventilated patients with chronic obstructive pulmonary disease with systolic pressure variations.

Authors:  David Lin Lee; Huan Lee; Hsueh-Wen Chang; Alice Y W Chang; Shoa-Lin Lin; Yuh-Chin T Huang
Journal:  Crit Care Med       Date:  2005-05       Impact factor: 7.598

8.  A comparison of noninvasive positive-pressure ventilation and conventional mechanical ventilation in patients with acute respiratory failure.

Authors:  M Antonelli; G Conti; M Rocco; M Bufi; R A De Blasi; G Vivino; A Gasparetto; G U Meduri
Journal:  N Engl J Med       Date:  1998-08-13       Impact factor: 91.245

9.  [Multicenter study on "non-invasive ventilation in patients with severe chronic obstructive pulmonary disease and emphysema(COPD)"].

Authors:  T Köhnlein; C P Criée; D Köhler; T Welte; G Laier-Groeneveld
Journal:  Pneumologie       Date:  2004-08

10.  Effects of assisted ventilation on the work of breathing: volume-controlled versus pressure-controlled ventilation.

Authors:  G Cinnella; G Conti; F Lofaso; H Lorino; A Harf; F Lemaire; L Brochard
Journal:  Am J Respir Crit Care Med       Date:  1996-03       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.